PFA
ELV icon

Pathway Financial Advisors’s Elevance Health ELV Stock Holding History

Pathway Financial Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-266
Closed -$63K – 169
2018
Q2 		$63K Hold
266
– – 0.04% 218
2018
Q1 		$58K Hold
266
– – 0.03% 224
2017
Q4 		$60K Buy
+266
New +$56.7K 0.03% 235

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pathway Financial Advisors's ELV Position: Q3 2018 in Review

Pathway Financial Advisors sold out of Elevance Health (ELV) in Q3 2018, closing a stake of 266 shares — an estimated $63K sold.

Pathway Financial Advisors first reported a position in ELV in Q4 2017 and held it in 3 quarters. The position peaked at $63K in Q2 2018. 945 funds tracked by Wall St. Rank hold ELV as of Q3 2018.

  • Pathway Financial Advisors reported no remaining Elevance Health position as of Q3 2018 after selling out during the quarter.
  • Pathway Financial Advisors sold 266 Elevance Health shares in Q3 2018, an estimated $63K.
  • Pathway Financial Advisors first reported a position in Elevance Health in Q4 2017 and held it in 3 quarters.
  • Pathway Financial Advisors's Elevance Health position peaked at $63K in Q2 2018.
  • 945 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.

Based on Pathway Financial Advisors's 13F filing for Q3 2018, filed 16 Jan 2019.